MyAverix Finance
US · Healthcare
Cardio Diagnostics Holdings Inc (CDIO)
Biotechnology
Cardio Diagnostics Holdings Inc (CDIO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $4.76M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CDIO
Cardio Diagnostics Holdings Inc (CDIO) — FAQ
What is Cardio Diagnostics Holdings Inc's market cap?
Cardio Diagnostics Holdings Inc (CDIO) has a reported market cap of $4.76M (data as of 2026-05-24).
What is CDIO's P/E ratio?
The price-to-earnings (P/E) ratio for Cardio Diagnostics Holdings Inc (CDIO) is 25.00 (data as of 2026-05-24).
Does Cardio Diagnostics Holdings Inc pay a dividend?
Dividend yield is not available in the current snapshot for Cardio Diagnostics Holdings Inc (CDIO). Check the MyAverix Finance app for the latest dividend data.
What sector is Cardio Diagnostics Holdings Inc in?
Cardio Diagnostics Holdings Inc (CDIO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CDIO listed on?
CDIO is listed on US.
What is Cardio Diagnostics Holdings Inc's net margin?
Cardio Diagnostics Holdings Inc (CDIO) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.